17015787

Source:http://linkedlifedata.com/resource/pubmed/id/17015787

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0086418, umls-concept:C0332307, umls-concept:C0439851, umls-concept:C1257901, umls-concept:C1280500, umls-concept:C1515655, umls-concept:C1552596, umls-concept:C1801960, umls-concept:C1947931
pubmed:issue	15
pubmed:dateCreated	2006-10-10
pubmed:abstractText	Protease-activated receptor type 1 (PAR-1) has been proposed as the principal thrombin receptor in humans, although its actions in vivo have not been defined. The aim of the present study was to determine the direct vascular actions of PAR-1 agonism in humans.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/15-Hydroxy-11 alpha,9..., http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, PAR-1, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, PAR-2, http://linkedlifedata.com/resource/pubmed/chemical/Thrombin, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents, http://linkedlifedata.com/resource/pubmed/chemical/seryl-leucyl-isoleucyl--glycyl-lysyl..., http://linkedlifedata.com/resource/pubmed/chemical/thrombin receptor peptide (42-47), http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1524-4539
pubmed:author	pubmed-author:FoxKeith A AKA, pubmed-author:GudmundsdóttirIngibjörg JIJ, pubmed-author:KellJillian SJS, pubmed-author:LudlamChristopher ACA, pubmed-author:MegsonIan LIL, pubmed-author:NewbyDavid EDE, pubmed-author:WebbDavid JDJ
pubmed:issnType	Electronic
pubmed:day	10
pubmed:volume	114
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1625-32
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:17015787-15-Hydroxy-11 alpha,9..., pubmed-meshheading:17015787-Adult, pubmed-meshheading:17015787-Blood Circulation, pubmed-meshheading:17015787-Cardiovascular Physiological Phenomena, pubmed-meshheading:17015787-Female, pubmed-meshheading:17015787-Humans, pubmed-meshheading:17015787-Male, pubmed-meshheading:17015787-Oligopeptides, pubmed-meshheading:17015787-Peptide Fragments, pubmed-meshheading:17015787-Platelet Activation, pubmed-meshheading:17015787-Platelet Aggregation, pubmed-meshheading:17015787-Receptor, PAR-1, pubmed-meshheading:17015787-Receptor, PAR-2, pubmed-meshheading:17015787-Thrombin, pubmed-meshheading:17015787-Tissue Plasminogen Activator, pubmed-meshheading:17015787-Vascular Resistance, pubmed-meshheading:17015787-Vasoconstriction, pubmed-meshheading:17015787-Vasoconstrictor Agents, pubmed-meshheading:17015787-Vasodilation, pubmed-meshheading:17015787-von Willebrand Factor
pubmed:year	2006
pubmed:articleTitle	Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans.
pubmed:affiliation	Centre for Cardiovascular Science, University of Edinburgh, Royal Infirmary, 49 Little France Crescent, Edinburgh, EH16 4SB, UK. Ingibjorg.Gudmunds@ed.ac.uk
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't